Intravesical epirubicin in the prophylaxis of superficial bladder cancer
✍ Scribed by F. Şengör; M. Beysel; K. Erdoĝan; A. Erol; D. Tuzluoĝlu
- Book ID
- 110553298
- Publisher
- Springer Netherlands
- Year
- 1996
- Tongue
- English
- Weight
- 248 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0301-1623
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background. The selection of the most appropriate antineoplastic agent and optimal treatment schedule for the prophylaxis of superficial bladder cancer against tumor recurrences is the subject of continual investigations. Methods. A controlled prospective trial involving 161 patients evaluated and
Proper care of patients with superficial bladder cancer requires the assessment of multiple factors, including an understanding of the natural history of this disease, accurate clinical staging, and the expected efficacy of each drug. The pharmacology of intravesical mytomycin C is discussed in deta